85 related articles for article (PubMed ID: 19767199)
1. Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden.
van Akkooi AC; Spatz A; Eggermont AM; Mihm M; Cook MG
Eur J Cancer; 2009 Nov; 45(16):2736-42. PubMed ID: 19767199
[TBL] [Abstract][Full Text] [Related]
2. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.
van der Ploeg AP; van Akkooi AC; Schmitz PI; Koljenovic S; Verhoef C; Eggermont AM
Eur J Cancer; 2010 Sep; 46(13):2414-21. PubMed ID: 20621467
[TBL] [Abstract][Full Text] [Related]
3. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.
Dewar DJ; Newell B; Green MA; Topping AP; Powell BW; Cook MG
J Clin Oncol; 2004 Aug; 22(16):3345-9. PubMed ID: 15310779
[TBL] [Abstract][Full Text] [Related]
4. Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma.
Fink AM; Weihsengruber F; Duschek N; Schierl M; Wondratsch H; Jurecka W; Rappersberger K; Steiner A
Melanoma Res; 2011 Apr; 21(2):139-43. PubMed ID: 21317817
[TBL] [Abstract][Full Text] [Related]
5. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM
Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339
[TBL] [Abstract][Full Text] [Related]
6. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
8. The detection and significance of melanoma micrometastases in sentinel nodes.
Scolyer RA; Murali R; Satzger I; Thompson JF
Surg Oncol; 2008 Sep; 17(3):165-74. PubMed ID: 18639451
[TBL] [Abstract][Full Text] [Related]
9. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
10. Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours.
Cochran AJ; Roberts A; Wen DR; Huang RR; Itakura E; Luo F; Binder SW
Pathology; 2004 Oct; 36(5):478-84. PubMed ID: 15370119
[TBL] [Abstract][Full Text] [Related]
11. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
Davids V; Kidson SH; Hanekom GS
Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
[TBL] [Abstract][Full Text] [Related]
12. Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap.
Riber-Hansen R; Nyengaard JR; Hamilton-Dutoit SJ; Steiniche T
Cancer; 2009 May; 115(10):2177-87. PubMed ID: 19288568
[TBL] [Abstract][Full Text] [Related]
13. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
[TBL] [Abstract][Full Text] [Related]
14. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients.
van der Ploeg AP; van Akkooi AC; Haydu LE; Scolyer RA; Murali R; Verhoef C; Thompson JF; Eggermont AM
Eur J Cancer; 2014 Jan; 50(1):111-20. PubMed ID: 24074765
[TBL] [Abstract][Full Text] [Related]
16. Metastatic melanoma cells in the sentinel node cannot be ignored.
Ollila DW; Ashburn JH; Amos KD; Yeh JJ; Frank JS; Deal AM; Long P; Thomas ND; Meyers MO
J Am Coll Surg; 2009 May; 208(5):924-9; discussion 929-30. PubMed ID: 19476863
[TBL] [Abstract][Full Text] [Related]
17. Detection of melanoma micrometastases in sentinel nodes - the cons.
de Wilt JH; van Akkooi AC; Verhoef C; Eggermont AM
Surg Oncol; 2008 Sep; 17(3):175-81. PubMed ID: 18617395
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.
Roulin D; Matter M; Bady P; Liénard D; Gugerli O; Boubaker A; Bron L; Lejeune FJ
Eur J Surg Oncol; 2008 Jun; 34(6):673-9. PubMed ID: 17825518
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
20. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
